FDA Approved: ETHOSUXIMIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA has approved a supplemental application for ethosuximide submitted by PAI Holdings/PAI Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Absence Seizures
• Epilepsy

Drugs mentioned

• Ethosuximide (ethosuximide)

Snippet

SUPPL AP for ETHOSUXIMIDE (ETHOSUXIMIDE)